Año: 2022
Journal Impact Factor (JIF): 158.50
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
MEDICINE, GENERAL & INTERNAL | SCIE | 2/169 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 24,510
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
MEDICINE, GENERAL & INTERNAL | 1/327 | Q1 | T1 | D1 | 99,85 |
Año:
2022
CiteScore:
134,400
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Medicine (all) | 1/830 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
26,015
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Medicine (miscellaneous) | 1/2531 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
BioMarin Pharmaceutical | - |
# | Autor | Afiliación |
---|---|---|
1 | State University of Campinas Faculty of Medical Sciences (Brazil) | |
2 | Mahlangu, J | University of Witwatersrand; National Health Laboratory Service (South Africa) |
3 | Pasi, KJ | Queen Mary University London (England) |
4 | Giermasz, A | University of California Davis (USA) |
5 | Leavitt, AD | University of California San Francisco (USA) |
6 | Laffan, M | Imperial College London (England) |
7 | Symington, E | University of Cambridge (England) |
8 | Quon, DV | Orthoped Hemophilia Treatment Ctr (USA) |
9 | Wang, JD | Taichung Veterans General Hospital (Taiwan) |
10 | Peerlinck, K | University Hospital Leuven (Belgium) |
11 | Pipe, SW | University of Michigan Department of Pathology; University of Michigan Department of Pediatrics (USA) |
12 | Madan, B | Guy's & St Thomas' NHS Foundation Trust (England) |
13 | Key, NS | University of North Carolina Chapel Hill (USA) |
14 | Pierce, GF | Sin datos () |
15 | O'Mahony, B | Trinity College Dublin; Irish Haemophilia Soc (Ireland) |
16 | Kaczmarek, R | Indiana University Bloomington; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences (USA) |
17 | Henshaw, J | BioMarin Pharmaceutical Inc. (USA) |
18 | Lawal, A | BioMarin Pharmaceutical Inc. (USA) |
19 | Jayaram, K | BioMarin Pharmaceutical Inc. (USA) |
20 | Huang, M | BioMarin Pharmaceutical Inc. (USA) |
21 | Yang, X | BioMarin Pharmaceutical Inc. (USA) |
22 | Wong, WY | BioMarin Pharmaceutical Inc. (USA) |
23 | Kim, B | BioMarin Pharmaceutical Inc. (USA) |
# | Autoría grupal | Afiliación |
1 | Mingot Castellano, Eva (GENEr8-1 Trial Group) | Sin datos () |
24 | GENEr8-1 Trial Group | Sin datos () |